JPMorgan, Jefferies and Piper Sandler are acting as joint book running managers for the offering.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on PTGX:
- 3 Stocks to Buy Today, 3/16/2023, According to Top Analysts
- Protagonist Therapeutics reports Q4 EPS (69c), consensus (64c)
- Protagonist Therapeutics price target raised to $38 from $33 at H.C. Wainwright
- Protagonist Therapeutics options imply 4.4% move in share price post-earnings
- Protagonist Therapeutics participates in a conference call with JPMorgan